Jad Chahoud, Chief Scientific and Innovation Officer at Orlando Health Cancer Institute, shared on LinkedIn:
”Grateful to have hosted Alain Mina (Yale University) at Orlando Health Cancer Institute for an outstanding Grand Rounds on redefining cure in AML across the transplant continuum.
Thank you, Alain, for sharing your expertise and spending time with our OHCI team.”
You can also read ‘Venetoclax + HMA in Newly Diagnosed AML: What Do Real-World Data Show?‘
